XML 31 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash flows from operating activities:    
Net income $ 4,707 $ 9,742
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 3,761 1,003
Change in fair value of contingent consideration 1,661 (2,786)
Share-based compensation expense 1,139 0
Amortization of deferred financing costs 76 200
Loss on extinguishment of debt 0 115
Issuance and vesting of Management Incentive Units 0 130
Participation unit compensation 0 23
Changes in operating assets and liabilities, net of effect of acquisitions:    
Premiums, commissions and fees receivable, net (5,221) (1,039)
Prepaid expenses and other current assets (634) (285)
Due from related parties 9 (7)
Accounts payable, accrued expenses and other current liabilities (527) (2,244)
Other liabilities 0 13
Net cash provided by operating activities 4,971 4,865
Cash flows from investing activities:    
Capital expenditures (583) (416)
Investment in business venture 0 (200)
Cash consideration paid for business combinations, net of cash received (39,305) (35,572)
Net cash used in investing activities (39,888) (36,188)
Cash flows from financing activities:    
Payment of guaranteed earnout consideration 0 (813)
Proceeds from revolving line of credit 20,000 29,304
Proceeds from related party debt 0 19,460
Payments on long-term debt 0 (204)
Payments of debt issuance costs and debt extinguishment costs (230) (15)
Proceeds from advisor incentive buy-ins 0 355
Proceeds received from repayment of stockholder/member notes receivable 41 45
Proceeds from issuance of common units 0 386
Repurchase of common units 0 (12,500)
Contributions 0 15
Distributions 0 (1,911)
Net cash provided by financing activities 19,811 34,122
Net increase (decrease) in cash and cash equivalents and restricted cash (15,106) 2,799
Cash and cash equivalents and restricted cash at beginning of period 71,071 7,995
Cash and cash equivalents and restricted cash at end of period 55,965 10,794
Supplemental schedule of cash flow information:    
Cash paid during the period for interest 573 1,275
Disclosure of non-cash investing and financing activities:    
Noncontrolling interest issued in business combinations 12,177 1,000
Contingent earnout consideration for business combinations 3,237 0
Change in the redemption value of redeemable interests 0 (33,271)
Capitalization of issuance to redeemable common member 0 5,509
Debt issuance costs added to revolving line of credit 0 2,554
Transfer of long-term debt to revolving line of credit $ 0 $ 1,820